Page last updated: 2024-09-02

fingolimod hydrochloride and carbostyril

fingolimod hydrochloride has been researched along with carbostyril in 19 studies

Compound Research Comparison

Studies (fingolimod hydrochloride)	Trials (fingolimod hydrochloride)	Recent Studies (post-2010) (fingolimod hydrochloride)	Studies (carbostyril)	Trials (carbostyril)	Recent Studies (post-2010) (carbostyril)
2,771	157	2,062	12,855	1,323	5,611

Research

Studies (19)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (21.05)	29.6817
2010's	15 (78.95)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burton, JM; O'Connor, P	1
Borriello, G; Cefaro, LA; Gasperini, C; Pozzilli, C; Prosperini, L; Tosto, G	1
Hartung, HP; Kieseier, BC; Stüve, O; Wiendl, H	1
Gasperini, C; Ruggieri, S	1
Fontoura, P; Garren, H	1
Fox, EJ	1
Gold, R	1
Jadidi-Niaragh, F; Mirshafiey, A	1
Csépány, T	1
Killestein, J; Polman, CH; Rudick, RA	1
Graham-Rowe, D	1
Ais-Larisgoitia, A; de Lorenzo-Pinto, A; Rodríguez-González, CG	1
Lassmann, H	1
Bandichhor, R; Iqbal, J; Mulakayala, N; Oruganti, S; Rao, P	1
di Nuzzo, L; Nasca, C; Nicoletti, F; Orlando, R	1
Carreón-Guarnizo, E; Hernández-Clares, R; Meca-Lallana, JE	1
Kretzschmar, B; Pellkofer, H; Weber, MS	1
Faissner, S; Gold, R	1
Ahn, SW; Cho, JY; Huh, SY; Hyun, JW; Kim, BJ; Kim, HJ; Kim, SH; Kim, W; Lee, SH; Park, MS	1

Reviews

15 review(s) available for fingolimod hydrochloride and carbostyril

Article	Year
Novel oral agents for multiple sclerosis. Current neurology and neuroscience reports, 2007, Volume: 7, Issue:3 Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cladribine; Clinical Trials as Topic; Dimethyl Fumarate; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Interferon beta-1b; Interferon-beta; Isoxazoles; Leflunomide; Minocycline; Multiple Sclerosis; Mycophenolic Acid; Propylene Glycols; Pyridones; Quinolones; Sphingosine	2007
Emerging oral drugs for multiple sclerosis. Expert opinion on emerging drugs, 2008, Volume: 13, Issue:3 Topics: Administration, Oral; Cladribine; Crotonates; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Immunosuppressive Agents; Multiple Sclerosis; Nitriles; Propylene Glycols; Quinolones; Sphingosine; Toluidines	2008
New oral drugs for multiple sclerosis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2009, Volume: 30 Suppl 2 Topics: Cladribine; Clinical Trials, Phase III as Topic; Crotonates; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Immunosuppressive Agents; Multiple Sclerosis; Nitriles; Propylene Glycols; Quinolones; Sphingosine; Toluidines	2009
Multiple sclerosis therapies: molecular mechanisms and future. Results and problems in cell differentiation, 2010, Volume: 51 Topics: Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Cladribine; Crotonates; Daclizumab; Dimethyl Fumarate; Encephalomyelitis, Autoimmune, Experimental; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Immunoglobulin G; Immunosuppressive Agents; Immunotherapy; Mice; Multiple Sclerosis; Myelin Basic Protein; Nitriles; Peptide Fragments; Propylene Glycols; Quinolones; Rituximab; Sphingosine; Toluidines; Vaccines, DNA	2010
Emerging oral agents for multiple sclerosis. The American journal of managed care, 2010, Volume: 16, Issue:8 Suppl Topics: 4-Aminopyridine; Cladribine; Clinical Trials as Topic; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Multiple Sclerosis; Propylene Glycols; Quinolones; Sphingosine	2010
Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved. CNS drugs, 2011, Volume: 25, Issue:1 Topics: Administration, Oral; Cladribine; Clinical Trials, Phase III as Topic; Crotonates; Dimethyl Fumarate; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Multiple Sclerosis; Nitriles; Propylene Glycols; Quinolones; Sphingosine; Toluidines	2011
Therapeutic approach to multiple sclerosis by novel oral drug. Recent patents on inflammation & allergy drug discovery, 2011, Volume: 5, Issue:1 Topics: Administration, Oral; Cladribine; Crotonates; Diterpenes; Epoxy Compounds; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Multiple Sclerosis; Nitriles; Patents as Topic; Phenanthrenes; Propylene Glycols; Quinolones; Sphingosine; Toluidines	2011
[Current treatment of multiple sclerosis]. Lege artis medicinae : uj magyar orvosi hirmondo, 2011, Volume: 21, Issue:2 Topics: Administration, Oral; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cladribine; Dimethyl Fumarate; Drug Administration Schedule; Fingolimod Hydrochloride; Fumarates; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon-beta; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Peptides; Propylene Glycols; Quinolones; Sphingosine; Treatment Outcome	2011
Oral treatment for multiple sclerosis. The Lancet. Neurology, 2011, Volume: 10, Issue:11 Topics: Administration, Oral; Cladribine; Clinical Trials as Topic; Crotonates; Dimethyl Fumarate; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Immunosuppressive Agents; Multiple Sclerosis, Relapsing-Remitting; Nitriles; Propylene Glycols; Quinolones; Sphingosine; Toluidines	2011
[Emerging therapies for multiple sclerosis]. Medicina clinica, 2013, Jan-19, Volume: 140, Issue:2 Topics: 4-Aminopyridine; Administration, Oral; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Cladribine; Clinical Trials as Topic; Crotonates; Daclizumab; Dimethyl Fumarate; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Immunoglobulin G; Immunosuppressive Agents; Middle Aged; Multicenter Studies as Topic; Multiple Sclerosis; Nitriles; Propylene Glycols; Quinolones; Rituximab; Sphingosine; Toluidines; Young Adult	2013
Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: a brief overview. European journal of medicinal chemistry, 2013, Volume: 60 Topics: Cladribine; Crotonates; Fingolimod Hydrochloride; Humans; Hydroxybutyrates; Molecular Structure; Multiple Sclerosis; Nitriles; Propylene Glycols; Quinolones; Small Molecule Libraries; Sphingosine; Toluidines	2013
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis. Drug design, development and therapy, 2014, Volume: 8 Topics: Administration, Oral; Animals; Blood-Brain Barrier; Crotonates; Dimethyl Fumarate; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Immune System; Multiple Sclerosis; NF-E2-Related Factor 2; Nitriles; Propylene Glycols; Quinolones; Sphingosine; Toluidines	2014
[Oral treatments in multiple sclerosis]. Medicina clinica, 2014, Volume: 143 Suppl 3 Topics: Administration, Oral; Crotonates; Dimethyl Fumarate; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Immunosuppressive Agents; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Nitriles; Propylene Glycols; Quinolones; Sphingosine; Toluidines	2014
The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis. Current neurology and neuroscience reports, 2016, Volume: 16, Issue:4 Topics: Animals; Clinical Trials as Topic; Crotonates; Dimethyl Fumarate; Fingolimod Hydrochloride; Humans; Hydroxybutyrates; Immunosuppressive Agents; Multiple Sclerosis; Nitriles; Quinolones; Toluidines	2016
Oral Therapies for Multiple Sclerosis. Cold Spring Harbor perspectives in medicine, 2019, 01-02, Volume: 9, Issue:1 Topics: Administration, Oral; Cladribine; Clinical Trials as Topic; Crotonates; Dimethyl Fumarate; Fingolimod Hydrochloride; Humans; Hydroxybutyrates; Immunosuppressive Agents; Multiple Sclerosis; Nitriles; Quinolones; Sphingosine 1 Phosphate Receptor Modulators; Toluidines	2019

Other Studies

4 other study(ies) available for fingolimod hydrochloride and carbostyril

Article	Year
The future of multiple sclerosis therapy. Pharmacological research, 2009, Volume: 60, Issue:4 Topics: Administration, Oral; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Cladribine; Crotonates; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Immunologic Factors; Injections, Intravenous; Injections, Subcutaneous; Interferon-beta; Multiple Sclerosis; Nitriles; Propylene Glycols; Quinolones; Sphingosine; Toluidines	2009
Drugs: An injection of hope. Nature, 2012, Apr-12, Volume: 484, Issue:7393 Topics: Alemtuzumab; Animals; Antibodies, Monoclonal, Humanized; Cladribine; Clinical Trials, Phase III as Topic; Crotonates; Dimethyl Fumarate; Disease Progression; Drug-Related Side Effects and Adverse Reactions; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Inflammation; Multiple Sclerosis; Natalizumab; Nitriles; Propylene Glycols; Quinolones; Risk Assessment; Sphingosine; Toluidines; United States; United States Food and Drug Administration	2012
Targeting intracerebral inflammation in multiple sclerosis: is it feasible? Acta neuropathologica, 2012, Volume: 124, Issue:3 Topics: Animals; Astrocytes; Blood-Brain Barrier; Ceramides; Demyelinating Diseases; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Multiple Sclerosis; NF-kappa B; Oligodendroglia; Propylene Glycols; Quinolones; Sphingosine	2012
Application of the 2017 McDonald diagnostic criteria for multiple sclerosis in Korean patients with clinically isolated syndrome. Multiple sclerosis (Houndmills, Basingstoke, England), 2019, Volume: 25, Issue:11 Topics: Adolescent; Adult; Crotonates; Demyelinating Diseases; Disease Progression; Female; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Hydroxybutyrates; Immunologic Factors; Immunosuppressive Agents; Interferon-beta; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Nitriles; Oligoclonal Bands; Optic Neuritis; Quinolones; Reproducibility of Results; Republic of Korea; Sensitivity and Specificity; Time Factors; Toluidines; Young Adult	2019